Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study page content appears unchanged; any differences are limited to formatting or UI elements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:34:18.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operational status details for the NIH Clinical Center, plus a new version tag v3.2.0. - Removed the old version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T15:57:35.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Page metadata updated: version bump to v3.1.0 with new date ranges; some past metadata removed and new future dates added. Overall, no substantive changes to core content or offerings.
    Difference
    0.6%
    Check dated 2025-09-29T09:54:24.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Page updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-15T00:12:44.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T20:39:22.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific cancer types and related proteins, while removing several previous cancer classifications and treatment categories. The facility name and location have also been added.
    Difference
    3%
    Check dated 2025-08-31T12:52:44.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.